Trial Profile

A Single Ascending Dose Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered SYN-020 Delayed Release Capsules in Healthy Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 28 Mar 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Alkaline phosphatase (Primary)
Indications Coeliac disease; Inflammatory bowel diseases; Metabolic syndrome; Non-alcoholic fatty liver disease; Radiation injuries
Focus Pharmacokinetics
Sponsors Synthetic Biologics; Theriva Biologics

Most Recent Events

13 Oct 2022 According to Theriva Biologics media release, Synthetic Biologics changed it's name to Theriva Biologics
07 Oct 2021 Status changed from active, no longer recruiting to completed.
29 Jun 2021 Preliminary Results published in the Synthetic Biologics Media Release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com